Naltrexone in bipolar disorder with depression: a double-blind, placebo-controlled study.

J Clin Psychopharmacol

Frazier Research Institute McLean Hospital Belmont, MA and Harvard Medical School Boston, MA Harvard Medical School Boston, MA and Laboratory for Psychiatric Biostatistics McLean Hospital Belmont, MA Frazier Research Institute McLean Hospital Belmont, MA and Harvard Medical School Boston, MA.

Published: December 2014

Download full-text PDF

Source
http://dx.doi.org/10.1097/JCP.0000000000000222DOI Listing

Publication Analysis

Top Keywords

naltrexone bipolar
4
bipolar disorder
4
disorder depression
4
depression double-blind
4
double-blind placebo-controlled
4
placebo-controlled study
4
naltrexone
1
disorder
1
depression
1
double-blind
1

Similar Publications

To evaluate weight change with a combination of olanzapine and samidorphan (OLZ/SAM) versus olanzapine by pooling data across clinical studies. This study was an individual patient data (IPD) meta-analysis of clinical trial data. EMBASE, MEDLINE, and PsycInfo were searched for randomized clinical trials (≥12 weeks) in adults with schizophrenia or bipolar I disorder in which weight change from baseline was the primary or secondary end point.

View Article and Find Full Text PDF
Article Synopsis
  • - The study evaluated the long-term safety, tolerability, and effect of olanzapine/samidorphan (OLZ/SAM) in patients with schizophrenia, schizophreniform disorder, or bipolar I disorder for up to 4 years, following the ENLIGHTEN clinical program.
  • - Out of 524 enrolled patients, the majority had schizophrenia, and common adverse effects included weight gain, headache, and anxiety, with minimal changes in metabolic parameters over the treatment duration.
  • - The treatment showed stable scores on the Clinical Global Impressions-Severity scale, indicating maintained symptom control and a long-term safety profile consistent with previous studies.
View Article and Find Full Text PDF

Binge eating disorder (BED) is the most common specific eating disorder (ED). It is frequently associated with attention deficit hyperactivity disorder (ADHD), depression, bipolar disorder (BD), anxiety disorders, alcohol and nicotine use disorder, and obesity. The aim of this narrative review was to summarize the evidence for the pharmacological treatment of BED and its comorbid disorders.

View Article and Find Full Text PDF

Studies have revealed that individuals with bipolar I and bipolar II have a past of substance abuse. The co-occurrence of bipolar disorder and alcoholism is frequent. Although various arguments have been put forward to explain the relationship between these disorders, it is still not fully understood.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!